Inventor · disambiguated record
Lawrence H. Fong
Also filed as: FONG LAWRENCE · FONG LAWRENCE H
7 granted patents·8 pending applications·36 citations·filing 2001–2021
76Inventor score
Top patents by PatentIndex Score
15 records- 0184US6423539B2Adjuvant treatment by in vivo activation of dendritic cellsUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Jul 23, 2002·36 cites·19 claims
- 0272US11892452B2Disease-associated antigens and methods of use thereofUNIV CALIFORNIA·Filed 2021·Granted Feb 6, 2024·0 cites·14 claims
- 0364US11016093B2Disease-associated antigens and methods of use thereofUNIV CALIFORNIA·Filed 2018·Granted May 25, 2021·0 cites·12 claims
- 0461US2022187299A1Methods of determining patient populations amenable to immunomodulatory treatment of cancerUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 0558US9945864B2Disease-associated antigens and methods of use thereofUNIV CALIFORNIA·Filed 2015·Granted Apr 17, 2018·0 cites·13 claims
- 0654US2016258025A1Predicting patient responsiveness to immune checkpoint inhibitorsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 0750US2022290247A1Compositions and methods for diagnosis and treatment of bladder cancerUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 0850US2011250218A1Disease-Associated Antigens and Methods of Use ThereofFONG LAWRENCE H·Filed 2009·Application pending·0 cites
- 0947US11215616B2Methods of determining patient populations amenable to immunomodulatory treatment of cancerUNIV CALIFORNIA·Filed 2016·Granted Jan 4, 2022·0 cites·6 claims
- 1045US2022033774A1Compositions and methods for cytotoxic cd4+ t cellsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1144US2017298440A1Materials and methods for improving the effectiveness of immunomodulatory cancer therapy and related methodologiesUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 1240US11699503B2Methods of identifying and treating patient populations amenable to cancer immunotherapyUNIV CALIFORNIA·Filed 2018·Granted Jul 11, 2023·0 cites·14 claims
- 1340US2020268795A1Interferon-gamma attenuates anti-tumor immune response to checkpoint blockadeUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1436US9046529B2Prostatitis-associated antigens and methods of use thereofFONG LAWRENCE H·Filed 2010·Granted Jun 2, 2015·0 cites·5 claims
- 1535US2015260730A1Prostatitis-associated antigens and methods of use thereofUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →